The global point of care (POC) molecular diagnostics market is expected to grow at a CAGR of 13.2% from 2019 to 2027 to reach at $2.39 billion by 2027 POC molecular diagnostics include portable devices and assays & kits used to detect and diagnose diseases in human samples, such as throat swab, blood, serum, and stool. […]Read More..
The growth of European Hospital Beds market is driven by the increasing elderly population coupled with growing prevalence of chronic diseases and launch of technologically advanced beds. Growing preference for minimally invasive surgeries and declining number of hospital and hospital beds in some of the European countries-hinders the growth of this market. On the other […]Read More..
With the growing need to achieve better value for healthcare, the importance of real-world evidence (RWE) as a decision-making tool and an important part of drug development and commercialization has also raised. Pharma and biopharma companies now recognize the need to get a better understanding and stronger evidence of product performance, clinical value and cost […]Read More..
With the growing need for early disease diagnosis and improved patient outcomes, in-vitro diagnostics is shifting from centralized laboratories to decentralized point-of-care (POC) testing. POC testing is gaining traction as it enables rapid detection of analytes near to the patient, which facilitates quick medical decisions and better disease diagnosis, monitoring, and management. The global point […]Read More..
Sterilization is one of the key processes in many of the industries, specifically in healthcare services. Sterilization Equipment are widely used in hospitals to prevent hospital acquired infections, and in pharmaceutical and biotechnology, medical device manufacturing, and food and beverages processing industry to maintain sterile processing environment within the facility, as per need. In industrial […]Read More..
The global antimicrobial susceptibility testing market is expected to grow at a CAGR of around 6.1% from 2019 to 2027 to reach at $5.09 billion by 2027. Susceptibility testing is used in the determination of the antimicrobials inhibiting the growth of the bacteria or fungi causing a specific infection. The aim of antimicrobial susceptibility testing […]Read More..
The Global Flow Cytometry Market is expected to grow at a CAGR of 8.2% from 2019 to 2027 to reach at $6.36 billion by 2027. Flow cytometry is a widely used method for analyzing cell size & volume, assessing the purity of isolated subpopulations, characterizing & defining different cell types in a heterogeneous cell population, […]Read More..
The clinical trial materials and supplies market is expected to grow at a CAGR of 6% from 2019 to reach $25.9 billion by 2025. Clinical trials have a vigorous supply chain management of the drugs considering the stringency of the regulations and the availability of the infrastructure for the efficient execution. The drug manufacturers and […]Read More..
The healthcare quality management market is characterized by constant technological advancements to keep pace with the changing regulatory and reporting needs. Aging and growing population, the proliferation of chronic diseases, heightened focus on care quality and value, evolving financial and quality regulations, informed and empowered consumers, and innovative treatments and technologies — all of which […]Read More..
Diabetes is currently one of the most pressing problems of the global healthcare systems and is regarded as one of the largest global health emergencies of 21st century. Diabetes is among the top 10 causes of death globally. Globally approximately 425 million adults between 20-79 years or 8.8% are estimated to have diabetes. With current […]Read More..